Pulmonary and blood stream infections in adult living donor and cadaveric liver transplant patients

Transplantation

Volumn 85, Issue 11, 2008, Pages 1564-1568

  Saner, Fuat H ^a,e   Damink, Steven W M Olde ^b   Pavlakovic, Goran ^c   Van Den Broek, Maartje A J ^b   Rath, Peter Michael ^d   Sotiropoulos, Georgios C ^a   Radtke, Arnold ^a   Canbay, Ali ^d   Paul, Andreas ^a   Nadalin, Silvio ^a   Malagó, Massimo ^a   Broelsch, Christoph E ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

^e Department of General Visceral Transplant Surgery ^*  (Germany)

Author keywords

Cadaveric donor; Infection; Living donor; Pneumonia.; Transplantation

Indexed keywords

AMPHOTERICIN B; COLISTIN; CYCLOSPORIN; FLUCONAZOLE; GANCICLOVIR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; SULTAMICILLIN; TACROLIMUS; TOBRAMYCIN;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BLOODSTREAM INFECTION; CADAVER DONOR; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GRAFT INFECTION; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INTENSIVE CARE; LIVER DISEASE; LIVER GRAFT; LIVING DONOR; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SAMPLE SIZE; SURVIVAL RATE; SURVIVAL TIME; TRANSPLANTATION; BACTERIAL PNEUMONIA; CADAVER; COMPARATIVE STUDY; DONOR; FOLLOW UP; GRAFT REJECTION; LIVER FAILURE; LIVER TRANSPLANTATION; METHODOLOGY; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SEPSIS;

CADAVER; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; INCIDENCE; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEPSIS; SURVIVAL RATE; TISSUE DONORS;

EID: 47049119917     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31816f61a6     Document Type: Article

References (27)

1. Rubin RH. The direct and indirect effects of infection in liver transplantation: Pathogenesis, impact, and clinical management. Curr Clin Top Infect Dis 2002; 22: 125.
2. Jensen WA, Rose RM, Hammer SM, et al. Pulmonary complications of orthotopic liver transplantation. Transplantation 1986; 42: 484.
3. Golfieri R, Giampalma E, Morselli Labate AM, et al. Pulmonary complications of liver transplantation: Radiological appearance and statistical evaluation of risk factors in 300 cases. Eur Radiol 2000; 10: 1169.
4. Singh N, Gayowski T, Wagener M, et al. Pulmonary infections in liver transplant recipients receiving tacrolimus. Changing pattern of micro-bial etiologies. Transplantation 1996; 61: 396.
5. Torres A, Ewig S, Insausti J, et al. Etiology and microbial patterns of pulmonary infiltrates in patients with orthotopic liver transplantation. Chest 2000; 117: 494.
6. Duran FG, Piqueras B, Romero M, et al. Pulmonary complications following orthotopic liver transplant. Transpl Int 1998; 11(suppl 1): S255.
7. SinghN,GayowskiT, Wagener MM,etal. Pulmonary infiltratesin liver transplant recipients in the intensive care unit. Transplantation 1999; 67: 1138.
8. Singh N, Paterson DL, Gayowski T, et al. Predicting bacteremia and bacteremic mortality in liver transplant recipients. Liver Transpl 2000; 6: 54.
9. Wade JJ, Rolando N, Hayllar K, et al. Bacterial and fungal infections after liver transplantation: Ananalysisof 284 patients.Hepatology1995; 21: 1328.
10. Wagener MM, Yu VL. Bacteremia in transplant recipients: A prospective study of demographics, etiologic agents, risk factors, and outcomes. Am J Infect Control 1992; 20: 239.
11. McClean K, Kneteman N, Taylor G. Comparative risk of bloodstream infection in organ transplant recipients. Infect Control Hosp Epidemiol 1994; 15: 582.
12. Fung JJ. Fungal infection in liver transplantation. Transpl Infect Dis 2002; 4(suppl 3): 18.
13. Collins LA, Samore MH, Roberts MS, et al. Risk factors for invasive fungal infections complicating orthotopic liver transplantation. J Infect Dis 1994; 170: 644.
14. Singh N, Gayowski T, Wagener MM, et al. Invasive fungal infections in liver transplant recipients receiving tacrolimus as the primary immu-nosuppressive agent. Clin Infect Dis 1997; 24: 179.
15. Castaldo P, Stratta RJ, Wood RP, et al. Clinical spectrum of fungal infections after orthotopic liver transplantation. Arch Surg 1991; 126: 149.
16. Wajszczuk CP, Dummer JS, Ho M, et al. Fungal infections in liver transplant recipients. Transplantation 1985; 40: 347.
17. Kusne S, Dummer JS, Singh N, et al. Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) 1988; 67: 132.
18. Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128.
19. Schindl MJ, Millar AM, Redhead DN, et al. The adaptive response of the reticuloendothelial system to major liver resection in humans. Ann Surg 2006; 243: 507.
20. Winston DJ, Pakrasi A, Busuttil RW. Prophylactic fluconazole in liver transplant recipients. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1999; 131: 729.
21. Lumbreras C, Cuervas-Mons V, Jara P, et al. Randomized trial of flu-conazole versus nystatin for the prophylaxis of Candida infection following liver transplantation. J Infect Dis 1996; 174: 583.
22. Singh N, Paterson DL, Gayowski T, et al. Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring renal replacement therapy. Transplantation 2001; 71: 910.
23. Edmond MB, Wallace SE, McClish DK, et al. Nosocomial bloodstream infections in United States hospitals: A three-year analysis. Clin Infect Dis 1999; 29: 239.
24. Jantunen E, Ruutu P, Piilonen A, et al. Treatment and outcome of invasive Aspergillus infectionsinallogeneic BMT recipients.Bone Marrow Transplant 2000; 26: 759.
25. Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348: 1546.
26. Rice LB. Antimicrobial resistance in gram-positive bacteria. Am J Med 2006; 119(6 suppl 1): S11.
27. Torre-Cisneros J, Herrero C, Canas E, et al. High mortality related with Staphylococcus aureus bacteremia after liver transplantation. Eur J Clin Microbiol Infect Dis 2002; 21: 385.